TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,457,000 | -86.4% | 139,907 | -92.5% | 0.04% | -88.2% |
| Q2 2021 | $18,101,000 | +62.8% | 1,866,073 | +80.3% | 0.34% | +36.8% |
| Q1 2021 | $11,116,000 | -0.8% | 1,034,991 | +35.9% | 0.25% | -16.8% |
| Q4 2020 | $11,201,000 | -5.1% | 761,465 | -8.3% | 0.30% | -23.3% |
| Q3 2020 | $11,801,000 | +132.7% | 830,497 | +32.5% | 0.39% | +92.5% |
| Q2 2020 | $5,071,000 | +91.7% | 626,810 | -4.3% | 0.20% | +6.3% |
| Q1 2020 | $2,645,000 | – | 654,781 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |